header advert
Results 1 - 3 of 3
Results per page:
The Bone & Joint Journal
Vol. 103-B, Issue 6 Supple A | Pages 13 - 17
1 Jun 2021
Park KJ Chapleau J Sullivan TC Clyburn TA Incavo SJ

Aims

Infection complicating primary total knee arthroplasty (TKA) is a common reason for revision surgery, hospital readmission, patient morbidity, and mortality. Increasing incidence of methicillin-resistant Staphylococcus aureus (MRSA) is a particular concern. The use of vancomycin as prophylactic agent alone or in combination with cephalosporin has not demonstrated lower periprosthetic joint infection (PJI) rates, partly due to timing and dosing of intravenous (IV) vancomycin administration, which have proven important factors in effectiveness. This is a retrospective review of a consecutive series of primary TKAs examining incidence of PJI, adverse reactions, and complications using IV versus intraosseous (IO) vancomycin at 30-day, 90-day, and one-year follow-up.

Methods

A retrospective review of 1,060 patients who underwent TKA between May 2016 to July 2020 was performed. There were 572 patients in the IV group and 488 in the IO group, with minimal 30 days of follow-up. Patients were followed up at regularly scheduled intervals (two, six, and 12 weeks). No differences between groups for age, sex, BMI, or baseline comorbidities existed. The IV group received an IV dose of 15 mg/kg vancomycin given over an hour preceding skin incision. The IO group received a 500 mg dose of vancomycin mixed in 150 ml of normal saline, injected into proximal tibia after tourniquet inflation, before skin incision. All patients received an additional dose of first generation cephalosporin. Evaluation included preoperative and postoperative serum creatinine values, tourniquet time, and adverse reactions attributable to vancomycin.


Orthopaedic Proceedings
Vol. 102-B, Issue SUPP_9 | Pages 16 - 16
1 Oct 2020
Park K Clyburn TA Sullivan TC Chapleau J Incavo SJ
Full Access

Introduction

Vancomycin is a commonly used antibiotic for prophylaxis in total joint replacement surgery. Several studies have reported superior local tissue concentration of vancomycin using intraosseous (IO) infusion compared with standard intravenous (IV) administration in total knee arthroplasty (TKA). We reviewed patients undergoing primary TKA who received IO vancomycin to a group receiving IV vancomycin.

Methods

A retrospective review of 1038 patient who underwent primary TKA at our institution was performed from May 1, 2016 to May 1, 2019. This was a consecutive series of patients before and after we adopted this technique. IO vancomycin administration technique has been previously reported from our institution (500mg vancomycin in 200mL solution). Comparisons included preoperative and postoperative creatinine values, adverse reaction to vancomycin, tourniquet time, re-operation rates, periprosthetic joint infection rate at 1 year.


Orthopaedic Proceedings
Vol. 101-B, Issue SUPP_4 | Pages 62 - 62
1 Apr 2019
Meheux C Park KJ Clyburn TA
Full Access

Background/Purpose

Patient-specific design (PSD) total knee arthroplasty (TKA) implants are marketed to restore neutral mechanical axis alignment (MAA) and provide better anatomic fit compared to standard off-the-shelf (OTS) TKA designs. The purpose of this study was to compare the Knee-Society scores, radiographic outcomes, and complications of PSD and OTS implants.

Methods

IRB approved prospective study comparing PSD and OTS by a single surgeon. Implant design change in PSD occurred during the study leading to PSD-1 and PSD-2 subgroups. Demographic, radiographic data including MAA, coronal-tibial angle (CTA), femoro-tibial angle (FTA), tibial-slope (TS) and patella-tilt (PT), and complications were analyzed. Minimum follow-up was 2 year or until revision, and patients completed Knee-Society scores preoperatively, and postoperatively at 3-, 6-, 12-, 24 weeks and final follow up.